Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents.
Tamer A OthmanMatthew G MeiJianying ZhangIbrahim AldossAnthony SteinStephen J FormanGuido MarcucciVinod A PullarkatPublished in: American journal of hematology (2021)